Webb5 okt. 2024 · The lay summary gives sponsors a framework to fulfill their legal commitments under EU Regulation 536/2014 Article 37, which requires them to file lay summaries of all pharmaceutical trials into the Clinical Trials Information System (CTIS). The new document provides a quick guide as well as a complete Good Lay Summary … Webb28 mars 2024 · Hi, this is the third in a series of blog posts regarding the risk adaptive approach, focusing on a pharmacokinetic (PK) clinical trial of ciprofloxacin administered off-label to neonates (please see previous post).This post described the development of a model combining a risk assessment with a more proportionate approach to the …
New UK MHRA Medical Devices Regulations Published - NAMSA
WebbThe study results, once available, should be posted to the website within 2 weeks of submission of the final study report (in turn usually submitted within 1 year of completion of data collection). 3 Some companies post the entire report (with redactions and stripped of the appendices) while others opt for posting the report abstract. WebbA summary of results for clinical trials of investigational medicinal products should be published in the registry where the clinical trial is registered within 6 months of the end … christophe laine
EU Clinical Trials Register - Update
WebbMarketing-authorisation holders must submit the results of studies on authorised medicines conducted in children to the European Medicines Agency (EMA) or to … WebbThe MHRA-GMDP database contains the following information issued by the MHRA relating to manufacturing and wholesale authorisations and certificates. Manufacturing … Webb3 feb. 2024 · Posted by: grahamcarroll, Posted on: 8 November 2024 - Categories: Good manufacturing practice In March 2024 the MHRA Inspectorate published a blog post in … christophe lager